✦ LIBER ✦

MRI for development of disease-modifying osteoarthritis drugs

✍ Scribed by Deborah Burstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lessons learned from nine clinical trial

✍ Kenneth D. Brandt; Steven A. Mazzuca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Systems to Assess the Progression of Fin

✍ G. Verbruggen; S. Goemaere; E. M. Veys 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 423 KB

Disease-modifying drugs for rheumatoid a

📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 207 KB

The relative toxicity of disease-modifyi

✍ James F. Fries; Catherine A. Williams; Dena Ramey; Daniel A. Bloch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB

Assessing long-term effects of disease-m

✍ Bernd C. Kieseier 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 359 KB

Clinical markers of therapeutic response

✍ Carlo Pozzilli; Luca Prosperini 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 32 KB